These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37265546)

  • 41. Targeting γ-Secretase for Familial Alzheimer's Disease.
    Wolfe MS
    Med Chem Res; 2021 Jul; 30(7):1321-1327. PubMed ID: 35295247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyloid Precursor Protein Changes Arrangement in a Membrane and Its Structure Depending on the Cholesterol Content.
    Krasnobaev VD; Bershatsky YV; Bocharova OV; Bocharov EV; Batishchev OV
    Membranes (Basel); 2023 Jul; 13(8):. PubMed ID: 37623767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42.
    Munter LM; Voigt P; Harmeier A; Kaden D; Gottschalk KE; Weise C; Pipkorn R; Schaefer M; Langosch D; Multhaup G
    EMBO J; 2007 Mar; 26(6):1702-12. PubMed ID: 17332749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
    Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
    Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides.
    Liu L; Lauro BM; Wolfe MS; Selkoe DJ
    J Biol Chem; 2021; 296():100393. PubMed ID: 33571524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-amyloid precursor protein mutants respond to gamma-secretase modulators.
    Page RM; Gutsmiedl A; Fukumori A; Winkler E; Haass C; Steiner H
    J Biol Chem; 2010 Jun; 285(23):17798-810. PubMed ID: 20348104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of membrane lipids on the activity and processivity of purified γ-secretase.
    Holmes O; Paturi S; Ye W; Wolfe MS; Selkoe DJ
    Biochemistry; 2012 May; 51(17):3565-75. PubMed ID: 22489600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and dynamic study of the transmembrane domain of the amyloid precursor protein.
    Nadezhdin KD; Bocharova OV; Bocharov EV; Arseniev AS
    Acta Naturae; 2011 Jan; 3(1):69-76. PubMed ID: 22649674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis.
    Zoltowska KM; Berezovska O
    Mol Neurobiol; 2018 Mar; 55(3):2275-2284. PubMed ID: 28332150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio.
    Xu TH; Yan Y; Kang Y; Jiang Y; Melcher K; Xu HE
    Cell Discov; 2016; 2():16026. PubMed ID: 27625790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific antibody binding to the APP672-699 region shifts APP processing from α- to β-cleavage.
    Li S; Deng J; Hou H; Tian J; Giunta B; Wang Y; Sawmiller D; Smith A; Sanberg PR; Obregon D; Mori T; Tan J
    Cell Death Dis; 2014 Aug; 5(8):e1374. PubMed ID: 25118934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
    J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Molecular Pathogenesis of Sporadic Alzheimer's Disease (AD) and Pharmaceutical Research to Develop a Biomarker for AD Diagnosis].
    Hata S
    Yakugaku Zasshi; 2015; 135(9):1023-7. PubMed ID: 26329547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. γ-Secretase, apolipoprotein E and cellular cholesterol metabolism.
    Walter J
    Curr Alzheimer Res; 2012 Feb; 9(2):189-99. PubMed ID: 21605030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer's disease pathogenesis.
    Li NM; Liu KF; Qiu YJ; Zhang HH; Nakanishi H; Qing H
    Neural Regen Res; 2019 Apr; 14(4):658-665. PubMed ID: 30632506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis.
    McLaurin J; Darabie AA; Morrison MR
    Ann N Y Acad Sci; 2002 Nov; 977():376-83. PubMed ID: 12480775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solid-State Structure of Abeta (Aβ) in Alzheimer's Disease.
    Lu JX; Dong XQ; Zhang JJ
    Protein Pept Lett; 2017; 24(4):322-330. PubMed ID: 28183246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
    Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of amyloid beta in lipid homeostasis.
    Grösgen S; Grimm MO; Friess P; Hartmann T
    Biochim Biophys Acta; 2010 Aug; 1801(8):966-74. PubMed ID: 20452461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.